Efficacy and safety of bevacizumab in elderly patients with metastatic colorectal cancer: results from the Czech population-based registry

por Slavicek, Lubomir, Pavlik, Tomas, Tomasek, Jiri, Bortlicek, Zbynek, Buchler, Tomas, Melichar, Bohuslav, Vyzula, Rostislav, Prausova, Jana, Finek, Jindrich, Majek, Ondrej, Dusek, Ladislav
Publicado 2014

Regorafenib for Metastatic Colorectal Cancer: An Analysis of a Registry-Based Cohort of 555 Patients

por Novakova-Jiresova, Alena, Kopeckova, Katerina, Boublikova, Ludmila, Chloupkova, Renata, Melichar, Bohuslav, Petruzelka, Lubos, Finek, Jindrich, Fiala, Ondrej, Grell, Peter, Batko, Stanislav, Linke, Zdenek, Kiss, Igor, Prausova, Jana, Buchler, Tomas
Publicado 2020

A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast...

por Goldstein, Lori J., Mansutti, Mauro, Levy, Christelle, Chang, Jenny C., Henry, Stephanie, Fernandez-Perez, Isaura, Prausovà, Jana, Staroslawska, Elzbieta, Viale, Giuseppe, Butler, Beth, McCanna, Susan, Ruffini, Pier Adelchi, Wicha, Max S., Schott, Anne F.
Publicado 2021

Exposure–response relationship of ramucirumab in patients with advanced second-line colorectal cancer: exploratory analysis of the RAISE trial

por Cohn, Allen Lee, Yoshino, Takayuki, Heinemann, Volker, Obermannova, Radka, Bodoky, György, Prausová, Jana, Garcia-Carbonero, Rocio, Ciuleanu, Tudor, Garcia-Alfonso, Pilar, Portnoy, David C., Van Cutsem, Eric, Yamazaki, Kentaro, Clingan, Philip R., Polikoff, Jonathon, Lonardi, Sara, O’Brien, Lisa M., Gao, Ling, Yang, Ling, Ferry, David, Nasroulah, Federico, Tabernero, Josep
Publicado 2017